Finance

Lists
Why is ALMR down 2.99%?
Dive Deeper
ALMR:NASDAQ
Alamar Biosciences Inc
$30.81
-2.99%
(-0.95) 1D
Nov 13, 4:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ALMR...
Open
$31.94
High
$31.94
Low
$29.21
Mkt. cap
2.14B
Avg. vol.
804.28K
Volume
667.71K
52-wk high
$39.61
52-wk low
$18.84
Shares outstanding
69.48M
No. of employees
308
Open
$31.94
High
$31.94
Low
$29.21
Mkt. cap
2.14B
Avg. vol.
804.28K
Volume
667.71K
52-wk high
$39.61
52-wk low
$18.84
Shares outstanding
69.48M
No. of employees
308
News stories
From web sources and news partners
About Alamar Biosciences Inc
CEO-
Employees308
Founded2018
Headquarters-
SectorHealth Care
Industry-
Websitealamarbio.com
Analyst ratings
Based on 2 analysts giving stock ratings to ALMR in the past 3 months
Buy
Buy
1
Hold
1
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for ALMR in the last 3 months.
Highest
Current $30.81
$36.00 (+16.85%)
Average
$36.00 (+16.85%)
Lowest
$36.00 (+16.85%)
Analyst
Recommendation
Action
Price target
Projected
Date
Michael Ryskin
Bank of America Securities
Hold
Maintained
-
-
11/04/2026
Daniel Brennan
TD Cowen
Buy
Reiterated
$36.00
+16.8%
11/04/2026
Casey Woodring
J.P. Morgan
Buy
Reiterated
$35.00
+13.6%
08/10/2026
Daniel Arias
Stifel Nicolaus
Buy
Maintained
$32.00
+3.9%
08/11/2026
Puneet Souda
Leerink Partners
Buy
Initiated
$35.00
+13.6%
05/12/2026
Last report
Nov 3, 2026
Fiscal period
Q3 2026
-$0.19 / -$0.19
-1.67%miss
Revenue / Est. (USD)
33.54M / 30.19M
+11.12%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
19.91M
26.04M
29.43M
33.54M
Cost of goods sold
8.02M
11.58M
11.71M
12.90M
Cost of revenue
8.02M
11.58M
11.71M
12.90M
Research and development expenses
10.21M
13.02M
13.82M
16.17M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
9.58M
13.79M
17.43M
19.62M
Operating expense
19.78M
26.80M
31.25M
35.78M
Total operating expenses
27.80M
38.38M
42.96M
48.68M
Operating income
-7.88M
-12.35M
-13.53M
-15.14M
Other non operating income
-
-
-
-
EBT including unusual items
-7.56M
-20.86M
-13.29M
-13.25M
EBT excluding unusual items
-7.56M
-12.27M
-11.92M
-13.25M
Income tax expense
440.00K
464.00K
-93.00K
94.00K
Effective tax rate
-5.82%
-2.22%
0.70%
-0.71%
Other operating expenses
-
-
-
-
Net income
-8.00M
-21.32M
-13.20M
-13.34M
Net profit margin
-40.18%
-81.91%
-44.85%
-39.77%
Earnings per share
-
-
-0.20
-0.19
Interest and investment income
410.00K
539.00K
1.88M
2.17M
Interest expense
-85.00K
-223.00K
-224.00K
-153.00K
Net interest expenses
325.00K
316.00K
1.65M
2.02M
Depreciation and amortization charges
-
-
-
-
EBITDA
-6.90M
-11.18M
-12.40M
-13.72M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps